US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?-Reference-Cited by-同舟云学术

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Published:2021-06-11 Issue:7 Volume:34 Page:1182-1186
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Piemonti Lorenzo¹^ORCID,Andres Axel²,Casey John³,Koning Eelco⁴,Engelse Marten⁴,Hilbrands Robert⁵,Johnson Paul⁶,Keymeulen Bart⁵,Kerr‐Conte Julie⁷^ORCID,Korsgren Olle⁸,Lehmann Roger⁹,Lundgren Torbjörn¹⁰,Maffi Paola¹,Pattou Francois⁷,Saudek Frantisek¹¹,Shaw James¹²,Scholz Hanne¹³,White Steve¹⁴,Berney Thierry²^ORCID

Affiliation:

1. Diabetes Research Institute IRCCS Ospedale San Raffaele Milan Italy

2. Department of Surgery Geneva University Hospitals Geneva Switzerland

3. Edinburgh Transplant Centre Royal Infirmary of Edinburgh Edinburgh UK

4. Department of Internal Medicine and Transplantation Center Leiden University Medical Center Leiden the Netherlands

5. Diabetes Research Center (DRC) Vrije Universiteit Brussel (VUB) Brussels Belgium

6. Nuffield Department of Surgical Sciences and Oxford Biomedical Research Centre (OxBRC) Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM) University of Oxford Oxford UK

7. Translational Research for Diabetes Inserm Centre Hospitalier Universitaire Lille Lille Pasteur Institute, U1190 European Genomic Institute for Diabetes University of Lille Lille France

8. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

9. Department Endocrinology, Diabetes and Clinical Nutrition University Hospital Zurich Zurich Switzerland

10. Division of Transplantation Surgery CLINTEC Karolinska Institutet Karolinska University Hospital Stockholm Sweden

11. Diabetes Center, Institute for Clinical and Experimental Medicine Prague Czech Republic

12. Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

13. Department of Transplantation Medicine Oslo University Hospital Oslo Norway

14. Department of HPB and Transplant Surgery The Freeman Hospital Newcastle Upon Tyne UK

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13930

Reference12 articles.

1. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

2. Phase 3 trial of human islet‐after‐kidney transplantation in type 1 diabetes

3. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial

4. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes

5. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scalable human islet 3D-culture platform maintains cell mass and function long-term for transplantation;American Journal of Transplantation;2024-02

2. Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas;Law, Technology and Humans;2023-11-21

3. Adipose‐Derived Stromal Cells Preserve Pancreatic Islet Function in a Transplantable 3D Bioprinted Scaffold;Advanced Healthcare Materials;2023-10-13

4. Legal and Regulatory Challenges for Emerging Regenerative Medicine Solutions for Diabetes;Transplantation;2023-09-26

5. Transplantation of Pancreatic Islets;The Pancreas;2023-08-04